Clinical Trials Directory

Trials / Unknown

UnknownNCT02213419

Endoscopic Ultrasonography-guided Double Ethanol Lavage for Pancreatic Cysts: a Prospective Cohort Study

EUS-guided Double Ethanol Lavage for Pancreatic Cysts: a Prospective Cohort Study

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Samsung Medical Center · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

Due to widespread use of cross-sectional imaging modalities, pancreatic cysts are common in abdominal image. These lesions encompass a wide spectrum, ranging from benign to malignant. The diagnosing specific type of cystic lesion is limited in spite of recent advances of diagnostic modalities. Surgical resection is generally recommended for malignant and potentially malignant lesions. However, surgical resection has significant morbidity and sometimes mortality. Recently, a few study of EUS-guided ethanol lavage for cystic tumors of the pancreas reported that complete resolution was achieved in only one-third of patients. Ethanol lavage of pancreatic cysts may be alternative method to surgical resection. The purpose of this study is the double ethanol lavage is a safe and effective method for treatment in those with the indeterminate pancreas cysts.

Conditions

Interventions

TypeNameDescription
DRUGEndoscopic ultrasonography-guided double ethanol lavageA radial echoendoscope and a 22 gauge needle were then used for cyst fluid aspiration and ethanol lavage. The 80 percent volume of cyst fluid was aspirated, and the pure ethanol was injected into the collapsed cyst until the original shape was restored. After 3-5 minutes, the reaspiration of the injected ethanol was then performed. The pure ethanol was reinjected into the collapsed cyst, followed by reaspiration of maximal possible volume for 3-5 minutes.

Timeline

Start date
2014-10-01
Primary completion
2016-08-01
Completion
2016-08-01
First posted
2014-08-11
Last updated
2015-02-12

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02213419. Inclusion in this directory is not an endorsement.